Used as a chiral organocatalyst in asymmetric synthesis, particularly in enantioselective cyclization and fluorination reactions. Its rigid bicyclic structure and chiral environment enable high stereoselectivity, making it valuable in pharmaceutical research for constructing stereocenters in complex molecules. The perfluorophenyl group enhances catalyst stability and influences electronic properties, improving reactivity in transformations involving electron-deficient substrates. Commonly applied in the development of bioactive compounds where precise stereochemistry is critical.